Did drug pricing bill pass? Ruff says it would damage ‘innovation’

RICHMOND – Depending on how the next week goes, Virginia could soon have a structure set up to control drug pricing. By a 26-13 vote on Friday, Feb. 3, the Virginia Senate voted to approve SB 957, also known as the Prescription Drug Affordability Board and Fund. 

The idea is to create a group of five individuals, all appointed by the governor and approved by the General Assembly. All of these people would have a background in healthcare. This group would be in charge of “identifying prescription, generic and other drugs that are offered for sale in the Commonwealth and, at the Board’s discretion, conduct an affordability review of any prescription drug product,” the bill states. 

Basically, this group would examine pricing of all prescription drugs in Virginia. If the board runs across a drug priced at the point it would cause “high out of pocket costs” for Virginia residents or in general is priced where most people who need it can’t afford it, then the board would be allowed to step in. They could establish an upper price limit on the drug. 

Again though, that’s if it passes the Virginia House, which it still needs to do. There was also some pushback on the bill from a local representative in the Virginia Senate. State Sen. Frank Ruff voted against SB 957, saying putting a cap on prices would “stifle innovation”. He also said he believed if drug prices were capped like this, pharmaceutical companies would leave Virginia for other states. He claimed it would drive jobs away. 

“If Virginia is going to compete for these jobs in this industry do we want to enact this type of legislation that sends the wrong message to the industry?” Ruff argued to the Senate. “Do we need to work to control cost? Yes, of course we do. But this sends the wrong message.” 

Speaking on the Senate floor, Ruff didn’t say what he saw as the right way to control cost. 

What happens next with drug pricing?

While Ruff opposed it, along with 12 other state senators, AARP has come out strong in support of the bill. The group presented an analysis Wednesday, detailing the fact that between July 2021 and July 2022, the price for more than 100 drugs grew faster than inflation in Virginia and across the country, climbing an estimated 32%. 

The bill was sent to the Virginia House Committee on Commerce and Energy on Wednesday, Feb. 8. It has not been scheduled for a hearing yet.

SportsPlus

Buckingham

VDOT issues warning ahead of Daylight Saving Time end

Buckingham

Herald Community Calendar for the week of Nov. 1, 2024

Cumberland

Cumberland Historical Society: How did Cumberland get its name?

Education

Superintendent Search: Parents, teachers speak up at meetings

College

Hampden-Sydney basketball set to help hurricane victims

Buckingham

Specialty store, events center considered in Buckingham County

Lifestyles

Renovations wrap up at LCVA

Farmville

Prince Edward Middle caps season with homecoming win

Cumberland

Cumberland Republicans set District 10 debate date and time

Cumberland

CCLA files lawsuit against county

Business

Sentence handed down in Envigo case, with millions in fines

Celebrations

Richmond Symphony Orchestra set for free concert in Farmville

Cumberland

Cumberland deals with latest school threat. FBI brought in to help

Buckingham

Buckingham honors ‘Academic All-Stars’

Buckingham

Frank Ruff passes away. State says goodbye to longtime lawmaker

Buckingham

Grateful Boomers find fun in nature, taking a hike at Pleasant Grove

College

Hampden-Sydney Tigers outlast visiting Averett University

Farmville

Farmville Leaf pickup set to start

Cumberland

Cumberland Students of the Month recognized

Buckingham

Herald Community Calendar for the week of Oct. 25, 2024

Buckingham

‘Right to Retrieve’ upheld by VA’s high court, hunters win

Buckingham

5th District Debate Pt. II: Candidates define equity, discuss defense

College

Hampden-Sydney Tigers add to basketball coaching staff

News

What does Executive Order 39 do?